PETMED EXPRESS INC

PetMed Express, Inc. (NASDAQ: PETS) operates as a leading nationwide direct-to-consumer pet health and wellness retailer through its brands PetMeds and PetCareRx. The company's website is www.petmeds.com.

Founded in 1996, PetMed Express pioneered the digital pet pharmacy space and has fulfilled orders for nearly twenty million pet parents across all fifty states. The company acquired PetCareRx in April 2023, significantly expanding its product offerings beyond prescription medications to include prescription and non-prescription pet foods, supplies, and wellness products. The company operates two pharmacy locations in Lynbrook, New York and Delray Beach, Florida, both licensed in all fifty states and accredited by the National Association of Boards of Pharmacy and LegitScript.

The core business involves marketing and selling prescription medications, generic medications, compounded prescriptions, over-the-counter health and wellness products, prescription and non-prescription foods, and pet supplies directly to consumers through websites, mobile applications, and customer contact centers. The company addresses common pet health conditions including allergies, arthritis, anxiety, heartworm, dermatitis, thyroid conditions, and diabetes for dogs, cats, and horses. A significant portion of sales derives from flea and tick preventatives and heartworm treatments. Approximately 62.6 percent of sales were generated through the AutoShip subscription program in the fourth quarter of fiscal 2026.

The company maintains a catalog of approximately 6,400 SKUs with approximately 88 percent of inventory spend concentrated among ten primary suppliers. More than 1.9 million customers have purchased from the company within the last three fiscal years, with approximately 50 percent of customers residing in Florida, California, Texas, New York, North Carolina, Pennsylvania, Virginia, and Georgia. The average order value was approximately ninety-eight dollars in fiscal 2026. The company attracted approximately 266,000 new customers in fiscal 2026.

As of March 31, 2026, the company employed 189 full-time employees. The company's strategy focuses on transitioning from a traditional e-commerce provider to a best-in-class pharmacy provider supported by scalable technology infrastructure, emphasizing clinical compliance, customer retention through loyalty programs, and diversifying revenue through B2B pharmacy fulfillment partnerships with veterinarians and strategic partners.